Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
Book now to reserve your spot and to be at the forefront of safeguarding healthcare data and infrastructure at the Convenzis Group' The Healthcare Cyber Security Conference in June.
Nearly 400 #health and #SocialCare providers across three Integrated Care Systems have collaborated to establish one of the UK’s largest shared care record using InterSystems HealthShare.
The initiative integrates the health and social care data of 3.2 million citizens into a unified record, enhancing…
Attendees
Sponsors and
Exhibitors
Media
Contact us